NCT00705562
Completed
Phase 2
Tolerance of Healthy Term Infants Fed Infant Formulas
ConditionsInfant, Newborn
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Infant, Newborn
- Sponsor
- Abbott Nutrition
- Enrollment
- 190
- Locations
- 15
- Primary Endpoint
- Gastrointestinal tolerance
- Status
- Completed
- Last Updated
- 17 years ago
Overview
Brief Summary
The objective of the study is to assess comparative gastrointestinal tolerance of normal term infants to various milk-protein infant formulas.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Healthy, term infants; singleton birth; 37-42 weeks of age; \>2490gms at birth; 0-8 days of age
Exclusion Criteria
- •medications/foods/formulas affecting GI tolerance;adverse medical history with possible effect on tolerance or growth
Outcomes
Primary Outcomes
Gastrointestinal tolerance
Time Frame: 0-8 days of age until 28 days of age
Secondary Outcomes
- GI and intake parameters(0-8 to 28 days of age)
Study Sites (15)
Loading locations...
Similar Trials
Completed
Phase 3
Tolerance of Healthy Term Infants Fed Infant Formulas #4Healthy Term InfantsNCT01155414Abbott Nutrition168
Completed
Phase 3
Tolerance of Healthy Term Infants Fed Infant Formulas #3Gastrointestinal ToleranceNCT00977964Abbott Nutrition270
Completed
Not Applicable
Tolerance of Healthy Infants Fed Infant FormulasGastrointestinal ToleranceNCT02401217Abbott Nutrition126
Completed
Phase 2
Tolerance of Healthy, Term Infants to Infant FormulasHealthyNCT00543673Abbott Nutrition180
Completed
Phase 3
Tolerance and Compliance of Infants Fed an Hydrolyzed Infant FormulaInfantGastrointestinal IntoleranceNCT01573871Abbott Nutrition25